EXCIVA GmbH

General Information

Company Name

EXCIVA GmbH

Founded Year

2015

Location (Offices)

Heidelberg, Germany +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Health Care, Pharmaceutical

Funding Stage

Series A

Social Media

EXCIVA GmbH - Company Profile

EXCIVA GmbH is a biotech startup based in Germany that focuses on Targeted Drug Rescue (TDR). The company recognizes the vast potential of repurposing approved drugs and abandoned compounds for new indications and uses. With over 3,000 approved drugs worldwide and many more abandoned compounds, EXCIVA GmbH aims to develop and market symptomatic and disease-modifying treatments, therapies, cures, prophylactics, and supplements. Their recent Series A investment of €9.00M on 26 October 2021 drew support from notable investors such as Andera Partner, Cure8 Ventures, and LBBW VC. The company's innovative approach, supported by its recent investment, positions it well within the Biotechnology, Healthcare, and Pharmaceutical industries. EXCIVA GmbH's commitment to repurposing existing drugs for new medical purposes marks it as a promising player in the biotech and pharmaceutical landscape.

Taxonomy: Drug development, Pharmaceutical research, Drug repurposing, Healthcare industry, Symptomatic treatments, Disease-modifying therapies, Prophylactics, Supplements, Formulations, Clinical trials, Biologics, Chemical compounds, Pharmaceutical industry, Medical innovation, Healthcare solutions